- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04739085
Level of Agreement Between Clinical Defocus Curves and the Web-based Democritus Digital Acuity Reading Test wDDART
Level of Agreement Between Clinical Defocus Curves and the Near and Intermediate Vision Web-based Democritus Digital Acuity Reading Test wDDART: a Comparative Study
Study Overview
Status
Conditions
Detailed Description
The 'defocus curve' assessment technique aims to simulate different distances from near to far over which the patient's visual acuity (VA) is evaluated. Defocus curves are created by first measuring best-corrected distance and near VA of the examinee. Then, a series of positive- and negative-powered trial lenses are added to the best-corrected distance visual acuity (BCDVA) of the patient's eye. Viewing through the addition of a minus lens creates divergent light rays with the same refractive effect as bringing the eye chart closer to the viewer. For instance, a -2.50 D lens represents the distance of 40 cm.
The "defocus curve" assessment technique is a method used widely for the assessment of the functional vision range following multifocal intraocular lens (IOL) implantation. Since this method is a simulation of the near vision, it would be ideal if near vision could be evaluated objectively with a near vision chart. However, the conventional printed near vision charts are not available for a variety of reading distances. In addition, the measurement of near VA at different distances with a printed reading chart intended for one predefined distance (e.g. printed chart for 40 cm) and the transformation of the reading score at 40 cm to an equivalent score for the examined distances is impractical in clinical setting.
For this reason, a digital reading test that allows the text calibration for all reading distances could be a practical method for the rapid and ease evaluation of the near VA, especially in patients implanted with multifocal IOLs. The web-based digital near and intermediate vision reading test wDDART offers the ability to estimate VA at different distances with automated measurement of the patient-screen distance.
Therefore, the present study aims to investigate the level of agreement between clinical defocus curves and the web-based digital near and intermediate vision reading test wDDART.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Evros
-
Alexandroupolis, Evros, Greece, 68100
- Recruiting
- Department of Ophthalmology, University Hospital of Alexandroupolis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients with previous cataract lens extraction will be categorized into the following groups:
- Monofocal group
- Monovision group (monofocal IOLs bilaterally)
- Hybrid monovision group (monofocal IOL in the dominant eye and multifocal IOL in the recessive eye)
- Bilateral multifocal group (the same multifocal IOLs bilaterally)
- Premium monovision group [bifocal hybrid IOL (Restor +2.50 diopters, Alcon) in the dominant eye and trifocal diffractive IOL (Panoptix, Alcon) in the recessive eye]
Description
Inclusion Criteria:
- Previous cataract lens extraction, age> 40 years, monocular best corrected distance visual acuity > 7/10
Exclusion Criteria:
- Glaucoma, corneal diseases, macular diseases, postoperative opacification of the posterior capsule, former mental diseases
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Defocus curve group
The monocular distance visual acuity of each participant' eye is evaluated using trial lenses of -3.00 sph, -2.50 sph, -1.75 sph, and -1.25 sph (added to the best correction for distance), which correspond to the distances of 30 cm, 40 cm, 60 cm, and 80 cm, respectively.
|
The monocular distance visual acuity of each participant' eye is evaluated using trial lenses of -3.00 sph, -2.50 sph, -1.75 sph, and -1.25 sph (added to the best correction for distance), which correspond to distances 30 cm, 40 cm, 60 cm and 80 cm, respectively.
|
|
wDDART group
The same participants undergo visual acuity test via the web-based digital near vision reading test wDDART at 30 cm, 40 cm, 60 cm and 80 cm, having their best correction for distance.
|
The same participants undergo visual acuity test via the web-based digital near vision reading test wDDART at 30 cm, 40 cm, 60 cm and 80 cm, having their best correction for distance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance-corrected near visual acuity (DCNVA) at 30 cm via defocus curves
Time Frame: through study completion, 6 months
|
The monocular distance visual acuity of each participant's eye is evaluated using a trial lens of -3.00 sph (added to the best correction for distance), which corresponds to the distance of 30 cm
|
through study completion, 6 months
|
|
Distance-corrected near visual acuity (DCNVA) at 40 cm via defocus curves
Time Frame: through study completion, 6 months
|
The monocular distance visual acuity of each participant's eye is evaluated using a trial lens of -2.50 sph (added to the best correction for distance), which corresponds to the distance of 40 cm
|
through study completion, 6 months
|
|
Distance-corrected intermediate visual acuity (DCIVA) at 60 cm via defocus curves
Time Frame: through study completion, 6 months
|
The monocular distance visual acuity of each participant's eye is evaluated using a trial lens of -1.75 sph (added to the best correction for distance), which corresponds to the distance of 60 cm
|
through study completion, 6 months
|
|
Distance-corrected intermediate visual acuity (DCIVA) at 80 cm via defocus curves
Time Frame: through study completion, 6 months
|
The monocular distance visual acuity of each participant's eye is evaluated using a trial lens of -1.25 sph (added to the best correction for distance), which corresponds to the distance of 80 cm
|
through study completion, 6 months
|
|
Distance-corrected near visual acuity (DCNVA) at 30 cm via wDDART
Time Frame: through study completion, 6 months
|
The monocular near (30 cm) visual acuity of each participant's eye is evaluated using the best correction for distance
|
through study completion, 6 months
|
|
Distance-corrected near visual acuity (DCNVA) at 40 cm via wDDART
Time Frame: through study completion, 6 months
|
The monocular near (40 cm) visual acuity of each participant's eye is evaluated using the best correction for distance
|
through study completion, 6 months
|
|
Distance-corrected intermediate visual acuity (DCIVA) at 60 cm via wDDART
Time Frame: through study completion, 6 months
|
The monocular intermediate (60 cm) visual acuity of each participant's eye is evaluated using the best correction for distance
|
through study completion, 6 months
|
|
Distance-corrected intermediate visual acuity (DCIVA) at 80 cm via wDDART
Time Frame: through study completion, 6 months
|
The monocular intermediate (80 cm) visual acuity of each participant's eye is evaluated using the best correction for distance
|
through study completion, 6 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ES1/Th4/21-1-2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Bruno Vision Careiuvo BioScience Operations, LLCCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
VIS, Inc.Active, not recruitingPresbyopia Correction
-
AST Products, Inc.CompletedCataract | Presbyopia CorrectionSpain
-
IROC AGAMO IrelandActive, not recruitingCataract | Presbyopia CorrectionSwitzerland
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
The Hong Kong Polytechnic UniversityNot yet recruitingPresbyopia | Presbyopia Correction
-
University Eye Hospital SvjetlostCompletedCataract | Visual Acuity | Presbyopia CorrectionCroatia